Edition:
United Kingdom

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

122.28USD
3:32pm BST
Change (% chg)

$1.26 (+1.04%)
Prev Close
$121.02
Open
$121.95
Day's High
$124.16
Day's Low
$121.63
Volume
29,336
Avg. Vol
104,399
52-wk High
$194.56
52-wk Low
$105.19

About

BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and... (more)

Overall

Beta: --
Market Cap(Mil.): $4,400.80
Shares Outstanding(Mil.): 3.26
Dividend: --
Yield (%): --

Financials

  BGNE.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -4.93 -- --
ROI: -57.59 8.90 13.82
ROE: -77.45 10.04 15.24

Earnings vs. Estimates